Colony to colorimetry in 6 h: ELISA detection of a surface-expressed Pseudomonas aeruginosa virulence factor using immobilized bacteria

被引:1
作者
Adawi, Azmi [1 ]
Neville, Lewis F. [1 ]
机构
[1] Lostam BioPharmaceut Ltd, IL-17111 Nazareth, Israel
关键词
Pseudomonas aeruginosa (PA); Flagellin; Monoclonal antibody (mAb); Multidrug resistant (MDR); Fixed ELISA; MONOCLONAL-ANTIBODIES; PNEUMONIA; INFECTION; FLAGELLIN; EPIDEMIOLOGY; CHALLENGE; INDUCE;
D O I
10.1016/j.diagmicrobio.2012.05.016
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A rapid ELISA employing intact Pseudomonas aeruginosa (PA) is described that allows discrimination between strains harboring flagellin type a or b. All 52 PA strains known to harbor flagellin type b were positive in this ELISA when screened with a fully human monoclonal antibody (LST-007) targeting flagellin type b. Completion of this assay in only 6 h, from picking a single bacterial colony to a colorimetric product, could easily be adapted to a clinical laboratory setting and permit the appropriate choice of therapeutic monoclonal antibody versus its homologous flagellin target in PA-infected patients. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:84 / 87
页数:4
相关论文
共 22 条
[1]  
Anderson TR, 1998, EUR J CLIN MICROBIOL, V7, P256
[2]   Therapy with anti-flagellin A monoclonal antibody limits Pseudomonas aeruginosa invasiveness in a mouse burn wound sepsis model [J].
Barnea, Yoav ;
Carmeli, Yehuda ;
Neville, Lewis F. ;
Kahel-Reifer, Hamutal ;
Eren, Rachel ;
Dagan, Shlomo ;
Nauon-Venezia, Shiri .
BURNS, 2009, 35 (03) :390-396
[3]   The biology and future prospects of antivirulence therapies [J].
Cegelski, Lynette ;
Marshall, Garland R. ;
Eldridge, Gary R. ;
Hultgren, Scott J. .
NATURE REVIEWS MICROBIOLOGY, 2008, 6 (01) :17-27
[4]   The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections [J].
Driscoll, James A. ;
Brody, Steven L. ;
Kollef, Marin H. .
DRUGS, 2007, 67 (03) :351-368
[5]   Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now [J].
Freire-Moran, Laura ;
Aronsson, Bo ;
Manz, Chris ;
Gyssens, Inge C. ;
So, Anthony D. ;
Monnet, Dominique L. ;
Cars, Otto .
DRUG RESISTANCE UPDATES, 2011, 14 (02) :118-124
[6]   Pneumonia Due to Pseudomonas aeruginosa Part I: Epidemiology, Clinical Diagnosis, and Source [J].
Fujitani, Shigeki ;
Sun, Hsin-Yun ;
Yu, Victor L. ;
Weingarten, Jeremy A. .
CHEST, 2011, 139 (04) :909-919
[7]   CLONING AND EXPRESSION OF PSEUDOMONAS-AERUGINOSA FLAGELLIN IN ESCHERICHIA-COLI [J].
KELLYWINTENBERG, K ;
MONTIE, TC .
JOURNAL OF BACTERIOLOGY, 1989, 171 (11) :6357-6362
[8]   INHIBITION OF BACTERIAL MOTILITY WITH HUMAN ANTIFLAGELLAR MONOCLONAL-ANTIBODIES ATTENUATES PSEUDOMONAS AERUGINOSA-INDUCED PNEUMONIA IN THE IMMUNOCOMPETENT RAT [J].
LANDSPERGER, WJ ;
KELLYWINTENBERG, KD ;
MONTIE, TC ;
KNIGHT, LS ;
HANSEN, MB ;
HUNTENBURG, CC ;
SCHNEIDKRAUT, MJ .
INFECTION AND IMMUNITY, 1994, 62 (11) :4825-4830
[9]   The challenge of multidrug resistance: The treatment of gram-negative rod infections [J].
Levin, Anna S. ;
Oliveira, Maura S. .
SHOCK, 2008, 30 :30-33
[10]   Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis [J].
Li, ZH ;
Kosorok, MR ;
Farrell, PM ;
Laxova, A ;
West, SEH ;
Green, CG ;
Collins, J ;
Rock, MJ ;
Splaingard, ML .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (05) :581-588